Results 111 to 120 of about 2,657,498 (292)
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims Chronic kidney disease (CKD) affects individual welfare, healthcare systems and societal progress. Of the multifaceted etiological factors, type 1 diabetes mellitus (T1DM) is a prominent contributor to CKD. Materials and Methods We analysed the global incidence, prevalence, deaths and disability‐adjusted life‐years (DALYs) with age ...
Jianran Sun +5 more
wiley +1 more source
Experience of surgical treatment of secondary hyperparathyroidism
Acta Biomedica Scientifica, 2016 Surgical treatment of secondary hyperparathyroidism (HPT) in patients having renal replacement therapy (RRT) is a current problem. The aim of our study was to optimize the treatment of secondary HPT based on the comparative analysis of effectiveness of ...
E. A. Ilyicheva +5 more
doaj +1 more source
Medicine, 2015 We compared 18F-fluorocholine hybrid positron emission tomography/X-ray computed tomography (FCH-PET/CT) with ultrasonography (US) and scintigraphy in patients with hyperparathyroidism and discordant, or equivocal results of US and 123I/99mTc-sesta ...
L. Michaud +10 more
semanticscholar +1 more source
Molecular mechanism for transcriptional regulation of the parathyroid hormone gene by Epiprofin
The FEBS Journal, EarlyView.The secretion of parathyroid hormone (PTH) from the chief cells in the parathyroid glands is regulated by the concentration of extracellular calcium. Epiprofin (Epfn) expression is induced by NFATc2 in response to elevated serum calcium, and Epfn negatively regulates PTH production.
Takashi Nakamura +8 more
wiley +1 more source
A 60-year-old man with chronic renal failure and a costal mass: a case report and review of the literature [PDF]
, 2009 Introduction Brown tumors are a rare focal manifestation of osteitis fibrosa cystica, which results from hyperparathyroidism. Chronic kidney failure may lead to secondary or tertiary hyperparathyroidism and thus to osteitis fibrosa cystica and brown ...
Campuzano-Zuluaga, Germán +2 more
core +3 more sources
The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism.
Nephrology, Dialysis and Transplantation, 2015 BACKGROUND Secondary hyperparathyroidism is a common condition in patients with end-stage renal disease and is associated with osteoporosis and cardiovascular disease.
K. Ivarsson +7 more
semanticscholar +1 more source
Bradycardia secondary to primary hyperparathyroidism
Journal of International Medical Research, 2019 Clinical doctors rarely associate hyperparathyroidism with significant bradyarrhythmia. We report a rare case of a patient initially misdiagnosed with primary sick sinus syndrome, which was eventually shown to be secondary to primary hyperparathyroidism.
Fei Liu +3 more
doaj +1 more source
Alkaline phosphatases in the complex chronic kidney disease-mineral and bone disorders [PDF]
, 2018 Alkaline phosphatases (APs) remove the phosphate (dephosphorylation) needed in multiple metabolic processes (from many molecules such as proteins, nucleotides, or pyrophosphate). Therefore, APs are important for bone mineralization but paradoxically they
Aguilar, Armando +8 more
core +1 more source
International Journal of Nephrology, 2015 The international burden of secondary hyperparathyroidism (SHPT) is unknown, but it may be estimable through the available chronic kidney disease and SHPT literature.
E. Hedgeman +5 more
semanticscholar +1 more source
X‐Linked Hypophosphataemia and Burosumab: A Systemic Disease With a New Treatment
Journal of Paediatrics and Child Health, EarlyView.ABSTRACT X linked hypophosphataemia (XLH) is a systemic, chronic condition that significantly impairs quality of life. In XLH, a phosphate regulating endopeptidase homologue X‐linked (PHEX) gene mutation leads to excess fibroblast growth factor 23 (FGF23), causing hypophosphataemia and subsequent rickets, lower limb deformity, pain and other sequelae ...
Jessica L. Sandy +5 more
wiley +1 more source